Henan Lingrui Pharmaceutical Future Growth
Future criteria checks 2/6
Henan Lingrui Pharmaceutical is forecast to grow earnings and revenue by 16.1% and 12.5% per annum respectively. EPS is expected to grow by 15.7% per annum. Return on equity is forecast to be 26.9% in 3 years.
Key information
16.1%
Earnings growth rate
15.7%
EPS growth rate
Pharmaceuticals earnings growth | 18.8% |
Revenue growth rate | 12.5% |
Future return on equity | 26.9% |
Analyst coverage | Low |
Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
An Intrinsic Calculation For Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Suggests It's 44% Undervalued
Oct 28Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Surges 33% Yet Its Low P/E Is No Reason For Excitement
Oct 13If EPS Growth Is Important To You, Henan Lingrui Pharmaceutical (SHSE:600285) Presents An Opportunity
Aug 07A Look At The Fair Value Of Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285)
Jul 03Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market
May 07Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point
May 02Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%
Mar 04Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?
Feb 29Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4,720 | 959 | 858 | 954 | 3 |
12/31/2025 | 4,194 | 820 | 739 | 818 | 3 |
12/31/2024 | 3,723 | 696 | 622 | 654 | 3 |
9/30/2024 | 3,564 | 676 | 611 | 655 | N/A |
6/30/2024 | 3,517 | 664 | 682 | 711 | N/A |
3/31/2024 | 3,432 | 614 | 756 | 777 | N/A |
12/31/2023 | 3,311 | 568 | 792 | 813 | N/A |
9/30/2023 | 3,232 | 526 | 847 | 865 | N/A |
6/30/2023 | 3,200 | 512 | 904 | 924 | N/A |
3/31/2023 | 3,108 | 479 | 805 | 830 | N/A |
12/31/2022 | 3,002 | 465 | 808 | 835 | N/A |
9/30/2022 | 2,917 | 440 | 654 | 696 | N/A |
6/30/2022 | 2,841 | 412 | 574 | 622 | N/A |
3/31/2022 | 2,786 | 396 | 637 | 707 | N/A |
12/31/2021 | 2,694 | 362 | 769 | 846 | N/A |
9/30/2021 | 2,635 | 383 | 663 | 741 | N/A |
6/30/2021 | 2,513 | 368 | 688 | 768 | N/A |
3/31/2021 | 2,430 | 346 | 460 | 536 | N/A |
12/31/2020 | 2,332 | 325 | 379 | 451 | N/A |
9/30/2020 | 2,215 | 302 | 367 | 424 | N/A |
6/30/2020 | 2,163 | 288 | 336 | 387 | N/A |
3/31/2020 | 2,068 | 270 | 386 | 428 | N/A |
12/31/2019 | 2,157 | 294 | 391 | 450 | N/A |
9/30/2019 | 2,149 | 292 | 442 | 479 | N/A |
6/30/2019 | 2,118 | 280 | 447 | 493 | N/A |
3/31/2019 | 2,078 | 270 | 413 | 460 | N/A |
12/31/2018 | 2,053 | 243 | 384 | 436 | N/A |
9/30/2018 | 2,139 | 240 | 319 | 420 | N/A |
6/30/2018 | 2,120 | 230 | N/A | 356 | N/A |
3/31/2018 | 1,990 | 223 | N/A | 201 | N/A |
12/31/2017 | 1,849 | 217 | N/A | 106 | N/A |
9/30/2017 | 1,697 | 198 | N/A | 18 | N/A |
6/30/2017 | 1,608 | 381 | N/A | 52 | N/A |
3/31/2017 | 1,513 | 364 | N/A | 107 | N/A |
12/31/2016 | 1,439 | 346 | N/A | 63 | N/A |
9/30/2016 | 1,315 | 365 | N/A | 113 | N/A |
6/30/2016 | 1,225 | 152 | N/A | 100 | N/A |
3/31/2016 | 1,133 | 141 | N/A | 110 | N/A |
12/31/2015 | 1,085 | 132 | N/A | 225 | N/A |
9/30/2015 | 1,006 | 119 | N/A | 251 | N/A |
6/30/2015 | 936 | 115 | N/A | 203 | N/A |
3/31/2015 | 901 | 97 | N/A | 173 | N/A |
12/31/2014 | 826 | 76 | N/A | 124 | N/A |
9/30/2014 | 802 | 75 | N/A | 130 | N/A |
6/30/2014 | 757 | 65 | N/A | 129 | N/A |
3/31/2014 | 718 | 59 | N/A | 130 | N/A |
12/31/2013 | 687 | 105 | N/A | 127 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600285's forecast earnings growth (16.1% per year) is above the savings rate (2.8%).
Earnings vs Market: 600285's earnings (16.1% per year) are forecast to grow slower than the CN market (26.2% per year).
High Growth Earnings: 600285's earnings are forecast to grow, but not significantly.
Revenue vs Market: 600285's revenue (12.5% per year) is forecast to grow slower than the CN market (13.9% per year).
High Growth Revenue: 600285's revenue (12.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600285's Return on Equity is forecast to be high in 3 years time (26.9%)